Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy (Q61637095)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 2000

Language	Label	Description	Also known as
English	Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy	scientific article published on 01 September 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Andrew D Zelenetz

6

object named as

A Zelenetz

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M Glenn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Z Rahman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M A Weiss

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D A Scheinberg

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D W Golde

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1577-1582

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995003%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose deoxycoformycin in lymphoid malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401892

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61637095&oldid=2222489727"